Showing results (81-90 of 114) with videos related to
Sort By:
Pageof 12
Cell Reports|June 9, 2025
Distinct TAM subset with cross-dressing capability determines the bifurcation of tumor immunityKanako Shimizu, An Sanpei, Hiroshi Nakazato, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
Evaluation of the function of human invariant NKT cells from cancer patients using alpha-galactosylceramide-loaded murine dendritic cellsKanako Shimizu, Michihiro Hidaka, Norimitsu Kadowaki, et al.Proceedings of the National Academy of Sciences of the United States of America|July 18, 2006
Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of miceShin-Ichiro Fujii, Kanako Shimizu, Hiroaki Hemmi, et al.Life Science Alliance|July 14, 2026
SATB1 preserves CD4<sup>+</sup> T-cell fidelity and establishes Treg function in antitumor immunityWooseok Seo, Chengcheng Zou, Kanako Shimizu, et al.Biochemical and Biophysical Research Communications|January 19, 2002
Identification and immunocytochemical analysis of DCNP1, a dendritic cell-associated nuclear proteinMasako Masuda, Satoru Senju, Shin-ichiro Fujii Si, et al.ACS Nano|January 5, 2019
End-Sealed High Aspect Ratio Hollow Nanotubes Encapsulating an Anticancer Drug: Torpedo-Shaped Peptidic NanocapsulesMotoki Ueda, Siyoong Seo, Baiju G Nair, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 2013
Invariant NKT cells induce plasmacytoid dendritic cell (DC) cross-talk with conventional DCs for efficient memory CD8+ T cell inductionKanako Shimizu, Miki Asakura, Jun Shinga, et al.Analytical and Bioanalytical Chemistry|July 11, 2019
Development of certified reference material NMIJ CRM 6205-a for the validation of DNA quantification methods: accurate mass concentrations of 600-bp DNA solutions having artificial sequencesSachie Shibayama, Shin-Ichiro Fujii, Kazumi Inagaki, et al.BMC Cancer|August 19, 2017
RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanomaDennis C Harrer, Bianca Simon, Shin-Ichiro Fujii, et al.The Journal of Experimental Medicine|December 7, 2005
Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cellsKang Liu, Juliana Idoyaga, Anna Charalambous, et al.Pageof 12